84 related articles for article (PubMed ID: 25308804)
21. Revised International Pediatric Non-Hodgkin Lymphoma Staging System.
Rosolen A; Perkins SL; Pinkerton CR; Guillerman RP; Sandlund JT; Patte C; Reiter A; Cairo MS
J Clin Oncol; 2015 Jun; 33(18):2112-8. PubMed ID: 25940716
[TBL] [Abstract][Full Text] [Related]
22. Secondary acute lymphoblastic leukaemia is constitutional and probably not related to prior therapy.
Ganzel C; Devlin S; Douer D; Rowe JM; Stein EM; Tallman MS
Br J Haematol; 2015 Jul; 170(1):50-5. PubMed ID: 25823602
[TBL] [Abstract][Full Text] [Related]
23. Treatment for Metastatic Penile Cancer After First-line Chemotherapy Failure: Analysis of Response and Survival Outcomes.
Wang J; Pettaway CA; Pagliaro LC
Urology; 2015 May; 85(5):1104-1110. PubMed ID: 25819619
[TBL] [Abstract][Full Text] [Related]
24. Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia.
Lana T; de Lorenzo P; Bresolin S; Bronzini I; den Boer ML; Cavé H; Froňková E; Stanulla M; Zaliova M; Harrison CJ; de Groot H; Valsecchi MG; Biondi A; Basso G; Cazzaniga G; te Kronnie G
Leukemia; 2015 Oct; 29(10):2107-10. PubMed ID: 25778098
[No Abstract] [Full Text] [Related]
25. Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment.
Eckert C; Hagedorn N; Sramkova L; Mann G; Panzer-Grümayer R; Peters C; Bourquin JP; Klingebiel T; Borkhardt A; Cario G; Alten J; Escherich G; Astrahantseff K; Seeger K; Henze G; von Stackelberg A
Leukemia; 2015 Aug; 29(8):1648-55. PubMed ID: 25748682
[TBL] [Abstract][Full Text] [Related]
26. Exposure-response analysis of rilotumumab in gastric cancer: the role of tumour MET expression.
Zhu M; Tang R; Doshi S; Oliner KS; Dubey S; Jiang Y; Donehower RC; Iveson T; Loh EY; Zhang Y
Br J Cancer; 2015 Feb; 112(3):429-37. PubMed ID: 25584489
[TBL] [Abstract][Full Text] [Related]
27. Statin use has negative clinical impact on non-germinal center in patients with diffuse large B cell lymphoma in rituximab era.
Song MK; Chung JS; Lee GW; Cho SH; Hong J; Shin DY; Shin HJ
Leuk Res; 2015 Feb; 39(2):211-5. PubMed ID: 25541029
[TBL] [Abstract][Full Text] [Related]
28. Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial.
Grignani G; Palmerini E; Ferraresi V; D'Ambrosio L; Bertulli R; Asaftei SD; Tamburini A; Pignochino Y; Sangiolo D; Marchesi E; Capozzi F; Biagini R; Gambarotti M; Fagioli F; Casali PG; Picci P; Ferrari S; Aglietta M;
Lancet Oncol; 2015 Jan; 16(1):98-107. PubMed ID: 25498219
[TBL] [Abstract][Full Text] [Related]
29. Intravenous 3-weekly paclitaxel and metronomic oral cyclophosphamide in patients with advanced urothelial cancer previously treated with gemcitabine and platinum.
Park JH; Lee JL
Cancer Chemother Pharmacol; 2015 Feb; 75(2):247-54. PubMed ID: 25428517
[TBL] [Abstract][Full Text] [Related]
30. Current status of antibody therapy in ALL.
Ai J; Advani A
Br J Haematol; 2015 Feb; 168(4):471-80. PubMed ID: 25382151
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia.
Kadia TM; Kantarjian HM; Thomas DA; O'Brien S; Estrov Z; Ravandi F; Jabbour E; Pemmaraju N; Daver N; Wang X; Jain P; Pierce S; Brandt M; Garcia-Manero G; Cortes J; Borthakur G
Am J Hematol; 2015 Feb; 90(2):120-4. PubMed ID: 25368968
[TBL] [Abstract][Full Text] [Related]
32. Predictors of delay in diagnosis and treatment in diffuse large B-cell lymphoma and impact on survival.
Nikonova A; Guirguis HR; Buckstein R; Cheung MC
Br J Haematol; 2015 Feb; 168(4):492-500. PubMed ID: 25324181
[TBL] [Abstract][Full Text] [Related]
33. Pilot trial of systemic methotrexate plus R-CHOP regimen with intrathecal methotrexate for simultaneous central nervous system and systemic diffuse large B cell lymphoma.
Yoo KH; Lee JY; Lim SH; Ko YH; Kim SJ; Kim WS
Acta Haematol; 2015; 133(2):179-82. PubMed ID: 25323539
[TBL] [Abstract][Full Text] [Related]
34. Risk-tailored CNS prophylaxis in a mono-institutional series of 200 patients with diffuse large B-cell lymphoma treated in the rituximab era.
Ferreri AJ; Bruno-Ventre M; Donadoni G; Ponzoni M; Citterio G; Foppoli M; Vignati A; Scarfò L; Sassone M; Govi S; Caligaris-Cappio F
Br J Haematol; 2015 Mar; 168(5):654-62. PubMed ID: 25312994
[TBL] [Abstract][Full Text] [Related]
35. Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis.
Daver N; Kantarjian H; Marcucci G; Pierce S; Brandt M; Dinardo C; Pemmaraju N; Garcia-Manero G; O'Brien S; Ferrajoli A; Verstovsek S; Popat U; Hosing C; Anderlini P; Borthakur G; Kadia T; Cortes J; Ravandi F
Br J Haematol; 2015 Mar; 168(5):646-53. PubMed ID: 25312977
[TBL] [Abstract][Full Text] [Related]
36. Relapsed Acute Lymphoblastic Leukemia.
Sidhu J; Gogoi MP; Krishnan S; Saha V
Indian J Pediatr; 2024 Feb; 91(2):158-167. PubMed ID: 37341952
[TBL] [Abstract][Full Text] [Related]
37. How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children.
Teachey DT; O'Connor D
Blood; 2020 Jan; 135(3):159-166. PubMed ID: 31738819
[TBL] [Abstract][Full Text] [Related]
38. Cyr61 participates in the pathogenesis of acute lymphoblastic leukemia by enhancing cellular survival via the AKT/NF-κB signaling pathway.
Zhu X; Song Y; Wu C; Pan C; Lu P; Wang M; Zheng P; Huo R; Zhang C; Li W; Lin Y; Cao Y; Li N
Sci Rep; 2016 Oct; 6():34018. PubMed ID: 27725691
[TBL] [Abstract][Full Text] [Related]
39. Childhood acute lymphoblastic leukemia: Integrating genomics into therapy.
Tasian SK; Loh ML; Hunger SP
Cancer; 2015 Oct; 121(20):3577-90. PubMed ID: 26194091
[TBL] [Abstract][Full Text] [Related]
40. CD22ΔE12 as a molecular target for RNAi therapy.
Uckun FM; Ma H; Cheng J; Myers DE; Qazi S
Br J Haematol; 2015 May; 169(3):401-14. PubMed ID: 25659406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
